In a long-standing collaboration with the lab of Matthias Edinger & Petra Hoffmann we are studying transcription networks controlling Treg function, as well as their TCR repertoir selection, in particular in the context of Graft-versus-Host-Disease (GvHD). Tregs are immuno-supressive and in a transplant setting, these cells can ameliorate GvHD and may thus be used therapeutically.
Michael Rehli • Dept. Internal Medicine III • University Hospital
F.-J.-Strauss Allee 11 • 93053 Regensburg • Germany
Imprint & Privacy